PADCEV® Combination Approved for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility Pfizer Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV®…
Anthem to Cover C2N Diagnostics’ PrecivityAD2® Blood Test, Expanding Access to Alzheimer’s Disease Diagnostics Beginning October 2026 C2N Diagnostics, LLC, a specialty diagnostics company focused on advancing precision medicine through…
Universal Orthodontic Lab Appoints Dr. Ryo Hamanaka as Chief Clinical Officer to Advance Clinical Innovation and Next-Generation Orthodontic Solutions Universal Orthodontic Lab, a leading orthodontic laboratory headquartered in Norwalk, California,…
OneLegacy Launches Western U.S.’s First Organ Procurement Organization-Based Ex Vivo Lung Perfusion Program to Expand Access to Lung Transplantation OneLegacy, the nonprofit organ procurement organization (OPO) serving Southern California, has…
LEO Pharma Reports Positive Phase 2 TRAPEDS-1 Results for Tralokinumab in Children with Moderate-to-Severe Atopic Dermatitis LEO Pharma A/S, a global company specializing in medical dermatology, has announced positive topline…
Auragens Named Stem Cell Treatment Center of the Year 2026, Earning Back-to-Back Recognition for Leadership in Regenerative Medicine Auragens has announced that it has been recognized as Stem Cell Treatment…
Studion Promotes Brian Harrington to General Manager of Life Sciences Business to Drive Growth of eClinical Services Studion, a technology services company specializing in the design, development, and delivery of…
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd, and Polpharma…
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate Bausch + Lomb Corporation a leading global eye health company dedicated to helping people see better to live better,…
Evolus Expands Aesthetic Portfolio with Exclusive U.S. Licensing Agreement for Profhilo®, Europe’s Leading Injectable Skin Quality Treatment Evolus, Inc., a global performance beauty company focused on developing innovative consumer aesthetic…
Bifrost Biosystems Signs Commercial Supply Agreement with Illumina to Accelerate Optical Pooled Screening Platform Launch Bifrost Biosystems has announced a significant commercial milestone with the signing of a supply agreement…
Retham Technologies Launches Next-Generation Cryoplatelets to Improve Platelet Research and Laboratory Testing Retham Technologies, Inc. has announced the commercial launch of Retham Cryoplatelets™, a next-generation functional platelet product developed to…